Rotigaptide (ZP123) Reverts Established Atrial Conduction Velocity Slowing

REFERENCES

• Aonuma S, Kohama Y, Akai K, Komiyama Y, Nakajima S, Wakabayashi M, Makino T. Studies on heart. XIX. Isolation of an atrial peptide that improves the rhythmicity of cultured myocardial cell clusters. Chem Pharm Bull (Tokyo) 1980; 28: 3332–3339, [CSA]
   PubMed Web of Science ®Google Scholar
• Xing D, Kjølbye A L, Nielsen M S, Petersen J S, Harlow K W, Holstein-Rathlou N -H, Martins J B. ZP123 increases gap junctional conductance and prevents reentrant ventricular tachycardia during myocardial ischemia in open chest dogs. J Cardiovasc Electrophysiol 2003; 14: 510–520, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Eloff B C, Gilat E, Wan X, Rosenbaum D S. Pharmacological modulation of cardiac gap junctions to enhance cardiac conduction: Evidence supporting a novel target for antiarrhythmic therapy. Circulation 2003; 108: 3157–3163, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Haugan K, Olsen K B, Hartvig L, Petersen J S, Holstein-Rathlou N -H, Hennan J K, Nielsen M S. The antiarrhythmic peptide analogue ZP123 prevents atrial conduction slowing during metabolic stress. J Cardiovasc Electrophysiol 2005; 16: 537–545, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hennan J K, Swillo R E, Morgan G A, Keith J C, Schaub R G, Smith R P, Feldman H S, Haugan K, Kantrowitz J, Wang P J, Abu-Qare A, Butera J, Larsen B D, Crandall D L. Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs. J Pharmacol Exp Ther: Epub 2005, DOI: 10.1124/jpet.105.096933[CSA]
   Google Scholar
• Muller A, Gottwald M, Tudyka T, Linke W, Klaus W, Dhein S. Increase in gap junction conductance by an antiarrhythmic peptide. Eur J Pharmacol 1997; 327: 65–72, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kjølbye A L, Knudsen C B, Jepsen T, Larsen B D, Petersen J S. Pharmacological Characterization of the New Stable Antiarrhythmic Peptide Analog Ac-D-Tyr-D-Pro-D-Hyp-Gly-D-Ala-Gly-NH2 (ZP123): In Vivo and in Vitro Studies. J Pharmacol Exp Ther 2003; 306: 1191–1199, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rohr S, Kucera J P, Kleber A G. Slow conduction in cardiac tissue, I: Effects of a reduction of excitability versus a reduction of electrical coupling on microconduction. Circ Res 1998; 83: 781–794, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Xing D, Kjølbye A L, Petersen J S, Martins J B. Pharmacological stimulation of cardiac gap junction coupling does not affect ischemia-induced focal ventricular tachycardia or triggered activity in dogs. Am J Physiol Heart Circ Physiol 2005; 288: H511–H516, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lampe P D, Lau A F. The effects of connexin phosphorylation on gap junctional communication. Int J Biochem Cell Biol 2004; 36: 1171–1186, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Weng S, Lauven M, Schaefer T, Polontchouk L, Grover R, Dhein S. Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation. FASEB J. 2002; 16: 1114–1116, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Dhein S, Larsen B D, Petersen J S, Mohr F W. Effects of the new antiarrhythmic peptide ZP123 on epicardial activation and repolarization pattern. Cell Commun Adhes 2003; 10: 371–378, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Axelsen L, Mohammed S, Kjølbye A L, Nielsen M S, Holstein-Rathlou N -H, Jensen O N, Andersen S, Hennan J K, Stahlhut M. Serine 297 and Serine 306: Two new phosphorylation sites involved in the regulation of connexin43 during ischemia. Circulation 2005; 112(17)II–114, Abstract No. 635[CSA]
   Google Scholar
• Schaffer P, Ahammer H, Muller W, Koidl B, Windisch H. Di-4-ANEPPS causes photodynamic damage to isolated cardiomyocytes. Pflugers Arch. 1994; 426: 548–551, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Qin H, Kay M W, Chattipakorn N, Redden D T, Ideker R E, Rogers J M. Effects of heart isolation, voltage-sensitive dye, and electromechanical uncoupling agents on ventricular fibrillation. Am J Physiol Heart Circ Physiol 2003; 284: H1818–H1826, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Liu Y, Cabo C, Salomonsz R, Delmar M, Davidenko J, Jalife J. Effects of diacetyl monoxime on the electrical properties of sheep and guinea pig ventricular muscle. Cardiovasc Res 1993; 27: 1991–1997, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar